Resultados de procura - Vivek Roy

Limitar resultados
  1. 1
    Safety and Efficacy of <i>nab</i>-Paclitaxel in the Treatment of Patients with Breast Cancer

    Safety and Efficacy of <i>nab</i>-Paclitaxel in the Treatment of Patients with Breast Cancer por Prakash Vishnu, Vivek Roy

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Beyond Trastuzumab: Small Molecule Tyrosine Kinase Inhibitors in HER-2–Positive Breast Cancer

    Beyond Trastuzumab: Small Molecule Tyrosine Kinase Inhibitors in HER-2–Positive Breast Cancer por Vivek Roy, Edith A. Perez

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors

    Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors por Vivek Roy, Catherine M. Verfaillie

    Publicado 1999
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety

    Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficac... por Saurav Das, Sikander Ailawadhi, Taimur Sher, Vivek Roy, Andre Fernandez, Ricardo Parrondo

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

    Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531) por Vivek Roy, Betsy LaPlant, Gerald G. Gross, Charles Bane, Frances M. Palmieri

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Bone Marrow Transplantation for Diamond-Blackfan Anemia

    Bone Marrow Transplantation for Diamond-Blackfan Anemia por Vivek Roy, Waleska S. Pérez, Mary Eapen, Judith Marsh, Marcelo C. Pasquini, Ricardo Pasqüini, Mahmoud M. Mustafa, Christopher Bredeson

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis

    Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis por Ayalew Tefferi, Daniel K. Partain, Jeanne Palmer, James L. Slack, Vivek Roy, William J. Hogan, Mark Litzow, Rhett P. Ketterling, Mrinal M. Patnaik

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

    Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma por Shaji Kumar, Betsy LaPlant, Wee Joo Chng, Jeffrey A. Zonder, Natalie S. Callander, Rafaël Fonseca, Briant Fruth, Vivek Roy, Charles Erlichman, A. Keith Stewart

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis

    Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis por Madiha Iqbal, Tea Reljic, Ernesto Ayala, Taimur Sher, Hemant S. Murthy, Vivek Roy, James M. Foran, Han W. Tun, Ambuj Kumar, Mohamed A. Kharfan‐Dabaja

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    A phase 2 study of vorinostat in acute myeloid leukemia

    A phase 2 study of vorinostat in acute myeloid leukemia por Élise Schaefer, Arturo Loaiza‐Bonilla, Mark Juckett, John F. DiPersio, Vivek Roy, James L. Slack, Wenting Wu, K. M. Laumann, Igor Espinoza‐Delgado, S. D. Gore

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

    Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer por Robert C. Flanigan, Sydney E. Salmon, Brent A. Blumenstein, Scott I. Bearman, Vivek Roy, Patrick C. McGrath, J. R. Caton, Nikhil C. Munshi, E. David Crawford

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

    Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma por Kristen Detweiler Short, S. Vincent Rajkumar, Dirk R. Larson, Francis K. Buadi, Suzanne R. Hayman, Angela Dispenzieri, Morie A. Gertz, Shaji Kumar, Joseph Mıkhael, Vivek Roy, Robert A. Kyle, Martha Q. Lacy

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

    A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma por Patrick B. Johnston, David J. Inwards, Joseph P. Colgan, Betsy LaPlant, Brian Kabat, Thomas M. Habermann, Ivana N. Micallef, Luis F. Porrata, Stephen M. Ansell, Craig B. Reeder, Vivek Roy, Thomas E. Witzig

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

    Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance por Shaji Kumar, Jesús G. Berdeja, Rubén Niesvizky, Sagar Lonial, Jacob P. Laubach, Mehdi Hamadani, A. Keith Stewart, Parameswaran Hari, Vivek Roy, Robert Vescio, Jonathan L. Kaufman, Deborah Berg, Eileen Liao, S. Vincent Rajkumar, Paul G. Richardson

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma

    A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma por Thomas E. Witzig, Kristina Laumann, Martha Q. Lacy, Suzanne R. Hayman, Angela Dispenzieri, Shaji Kumar, Craig B. Reeder, Vivek Roy, John A. Lust, Morie A. Gertz, Philip R. Greipp, Hani Hassoun, Sumithra J. Mandrekar, S. Vincent Rajkumar

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    <i>Cytokeratin-19</i> and <i>Mammaglobin</i> Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437

    <i>Cytokeratin-19</i> and <i>Mammaglobin</i> Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Tria... por Monica M. Reinholz, Kathleen Kitzmann, Kathleen Tenner, David W. Hillman, Amylou C. Dueck, Timothy J. Hobday, Donald W. Northfelt, Alvaro Moreno‐Aspitia, Vivek Roy, Betsy LaPlant, Jake Allred, Philip J. Stella, Wilma L. Lingle, Edith A. Perez

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities por Sikander Ailawadhi, Ryan D. Frank, Mayank Sharma, Richa Menghani, M’hamed Temkit, Shumail M. Paulus, Nandita Khera, Shahrukh K. Hashmi, Pooja Advani, Abhisek Swaika, Aneel Paulus, Nabeel Aslam, Taimur Sher, Vivek Roy, Gerardo Colón‐Otero, Asher Chanan‐Khan

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia por Vivek Kumar, Sikander Ailawadhi, Leyla Bojanini, Aditya Mehta, Suman Biswas, Taimur Sher, Vivek Roy, Prakash Vishnu, Julian A. Marin‐Acevedo, Victoria R. Alegria, Aneel Paulus, Sonikpreet Aulakh, Madiha Iqbal, Rami Manochakian, Winston Tan, Asher Chanan‐Khan, Meghna Ailawadhi

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

    Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis por Tania Jain, Katie L. Kunze, M’hamed Temkit, Daniel K. Partain, Mrinal M. Patnaik, James L. Slack, Nandita Khera, William J. Hogan, Vivek Roy, Pierre Noël, José F. Leis, Lisa Z. Sproat, Veena Fauble, Ruben A. Mesa, Jeanne Palmer

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Unrelated Donor Marrow Transplantation for B-Cell Chronic Lymphocytic Leukemia After Using Myeloablative Conditioning: Results From the Center for International Blood and Marrow Transplant Research

    Unrelated Donor Marrow Transplantation for B-Cell Chronic Lymphocytic Leukemia After Using Myeloablative Conditioning: Results From the Center for International Blood and Marrow Tr... por Steven Z. Pavletic, Issa F. Khouri, Michael Haagenson, Roberta King, Philip J. Bierman, Michael R. Bishop, Michael J. Carston, Sergio Giralt, Arturo Molina, Edward A. Copelan, Olle Ringdén, Vivek Roy, Karen K. Ballen, Douglas R. Adkins, Philip L. McCarthy, Daniel J. Weisdorf, Emili Montserrat, Claudio Anasetti

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: